Send to

Choose Destination
Nat Med. 1997 May;3(5):515-20.

Targeting gene expression to hypoxic tumor cells.

Author information

Experimental Oncology Division, Medical Research Council, Harwell, UK.


Solid tumors with areas of low oxygen tension (hypoxia) have a poor prognosis, as cells in this environment often survive radiation and chemotherapy. In this report we describe how this hypoxic environment can be used to activate heterologous gene expression driven by a hypoxia-responsive element (HRE), which interacts with the transcriptional complex hypoxia-inducible factor-1 (HIF-1). Our results demonstrate that the HIF-1/HRE system of gene regulation is active in hypoxic tumor cells and show the potential of exploiting tumor-specific conditions for the targeted expression of diagnostic or therapeutic genes in cancer therapy.

[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center